Sun Pharmaceutical Industries Ltd.

NSE: SUNPHARMA | BSE: 524715 | ISIN: INE044A01036 | Industry: Pharmaceuticals
| Expensive Performer
1683.4500 6.60 (0.39%)
NSE Mar 13, 2025 15:31 PM
Volume: 1.7M
 

logo
Sun Pharmaceutical Industries Ltd.
21 Jan 2025
1683.45
0.39%
buy
by Emkay
Target: 2400 | Upside : 42.6%
Emkay
J&J, in a recent investor interaction, had stated that its oral IL-23 receptor antagonist peptide (Icotrokinra) could potentially compete with existing oral as well as injectable treatment options for moderate to severe plaque psoriasis.
 
ICICI Securities Limited upgraded Sun Pharmaceutical Industries Ltd. to Buy with a price target of 1895.0 on 11 Mar, 2025.
More from Sun Pharmaceutical Industries Ltd.
Recommended
Five Interesting Stocks Today - March 13, 2025
The Baseline | 13 Mar 2025, 04:51PM
Market closes lower, Kolte Patil Developers to raise Rs 417 crore via preferential issue
Trendlyne Marketwatch | 13 Mar 2025, 03:52PM
Change is hard, and some Indian pharma companies are embracing it better than others
| 09 Aug 2022